Healthcare Finance News August 5, 2024
Jeff Lagasse

JelloX Biotech has developed 3D pathology imaging technology with AI for spatial analysis to support precision cancer diagnoses.

Minnesota-based Mayo Clinic is joining forces with 3D imaging startup JelloX Biotech on artificial intelligence-powered imaging analysis technology.

JelloX previously participated in the fifth cohort of the Mayo Clinic and Arizona State University Alliance for Health Care MedTech Accelerator, a flagship program providing early-stage medical device and healthcare technology companies with curriculum to accelerate their go-to-market plans.

The company has developed 3D pathology imaging technology with AI for spatial analysis to support precision cancer diagnoses, with Mayo Clinic expected to further develop and validate the technology.

WHAT’S THE IMPACT

According to Mayo, cancer diagnoses using traditional 2D imaging methods can miss spatial...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Provider, Radiology, Technology
How 3 hospitals are reimagining behavioral crisis care
How Health Systems Can Collaborate on AI Tools
Critical access hospitals face uphill battle: 6 things to know
AdventHealth's plans for new Florida hospital move forward
OSU Wexner CEO's blueprint for improving care in 2025

Share This Article